Folate-modified–chitosan-coated liposomes for tumor-targeted drug delivery
Source abstract
Abstract
In this study, a folate-modified–chitosan-coated liposome (FCCL) was prepared for tumor-targeted drug delivery. The folate–chitosan conjugates were characterized using 1H NMR and infrared spectrum analysis. The properties of folate–chitosan-coated liposomes (FCCLs) were studied and compared with those of traditional liposomes and chitosan-coated liposomes (CCLs). FCCLs were spherical in shape with a classic core–shell structure. Compared with conventional liposomes, FCCLs had larger size (average diameter: 182.0 nm), higher zeta potential (10.1 mV), prolonged drug release behaviors (55.76 % after 24 h), and better physical stability when stored at 25 °C, all similar to the properties of CCLs. With fluorescein as a model drug, fluorescein-loaded liposomes, CCLs, and FCCLs were prepared and their tumor targeting ability was evaluated according to the in vitro cellular uptake of fluorescein loaded nanoparticles by MCF-7 and HUVEC cells. Results demonstrated that FCCLs had a significant higher uptake by folate receptor positive cells (MCF-7) as compared to traditional liposomes and CCLs, which indicated that the FCCLs were promising nano-carriers for tumor-targeted drug delivery.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Advanced biosensing and bioanalysis techniques · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (46)
Show source-provided references
1. Bhosle J, Hall G (2009) Surgery (Oxford) 27:173. doi: 10.1016/j.mpsur.2009.01.00610.1016/j.mpsur.2009.01.006 ↗
2. Gómez-Hens A, Fernández-Romero JM (2006) Trends Anal Chem 25:167. doi: 10.1016/j.trac.2005.07.00610.1016/j.trac.2005.07.006 ↗
3. Coimbra M, Isacchi B, van Bloois L et al (2011) Int J Pharm 416:433. doi: 10.1016/j.ijpharm.2011.01.05610.1016/j.ijpharm.2011.01.056 ↗
4. Torchilin VP (2005) Nat Rev Drug Discov 4:14510.1038/nrd1632 ↗
5. Harrington KJ, Syrigos KN, Vile RG (2002) J Pharm Pharmacol 54:1573. doi: 10.1211/002235700224310.1211/0022357002243 ↗
6. Grit M, de Smidt JH, Struijke A, Crommelin DJA (1989) Int J Pharm 50:1. doi: 10.1016/0378-5173(89)90173-710.1016/0378-5173(89)90173-7 ↗
7. Graff A, Winterhalter M, Meier W (2001) Langmuir 17:919. doi: 10.1021/la001306m10.1021/la001306m ↗
8. Taylor TM, Davidson PM, Bruce BD, Weiss J (2005) Crit Rev Food Sci Nutr 45:58710.1080/10408390591001135 ↗
9. Zhang L, Granick S (2006) Nano Lett 6:69410.1021/nl052455y ↗
10. Mady MM, Darwish MM, Khalil S, Khalil WM (2009) Eur Biophys J 38:112710.1007/s00249-009-0524-z ↗
11. Henriksen I, Smistad G, Karlsen J (1994) Int J Pharm 101:227. doi: 10.1016/0378-5173(94)90218-610.1016/0378-5173(94)90218-6 ↗
12. Liang X, Wang H, Jiang X, Chang J (2010) J Nanopart Res 12:1723. doi: 10.1007/s11051-010-9896-310.1007/s11051-010-9896-3 ↗
13. Chen X-G, Liu C-S, Liu C-G, Meng X-H, Lee CM, Park H-J (2006) Biochem Eng J 27:269. doi: 10.1016/j.bej.2005.08.02110.1016/j.bej.2005.08.021 ↗
14. Ghosh A, Ali M (2012) J Mater Sci 47:1196. doi: 10.1007/s10853-011-5885-x10.1007/s10853-011-5885-x ↗
15. Liu W, Chen G, He G, He Z, Qian Z (2011) J Mater Sci 46:6758. doi: 10.1007/s10853-011-5632-310.1007/s10853-011-5632-3 ↗
16. Yin W, Su R, Qi W, He Z (2012) J Mater Sci 47:2045. doi: 10.1007/s10853-011-6005-710.1007/s10853-011-6005-7 ↗
17. Henriksen I, Våagen SR, Sande SA, Smistad G, Karlsen J (1997) Int J Pharm 146:193. doi: 10.1016/s0378-5173(96)04801-610.1016/S0378-5173(96)04801-6 ↗
18. Takeuchi H, Matsui Y, Yamamoto H, Kawashima Y (2003) J Controlled Release 86:235. doi: 10.1016/s0168-3659(02)00411-x10.1016/S0168-3659(02)00411-X ↗
19. Wang H, Zhao P, Liang X et al (2010) Biomaterials 31:4129. doi: 10.1016/j.biomaterials.2010.01.08910.1016/j.biomaterials.2010.01.089 ↗
20. Zhao P, Wang H, Yu M et al (2012) Eur J Pharm Biopharm 81:248. doi: 10.1016/j.ejpb.2012.03.00410.1016/j.ejpb.2012.03.004 ↗
21. Su W, Wang H, Wang S et al (2012) Int J Pharm 426:170. doi: 10.1016/j.ijpharm.2012.01.01310.1016/j.ijpharm.2012.01.013 ↗
22. Takeuchi H, Yamamoto H, Niwa T, Hino T, Kawashima Y (1996) Pharm Res 13:89610.1023/A:1016009313548 ↗
23. Kozlova NO, Bruskovskaya IB, Okuneva IB et al (2001) Biochim Biophys Acta 1514:13910.1016/S0005-2736(01)00381-9 ↗
24. Guo J, Ping Q, Jiang G, Huang L, Tong Y (2003) Int J Pharm 260:167. doi: 10.1016/s0378-5173(03)00254-010.1016/S0378-5173(03)00254-0 ↗
25. Takeuchi H, Yamamoto H, Niwa T, Hino T, Kawashima Y (1994) Chem Pharm Bull 42:195410.1248/cpb.42.1954 ↗
26. Bae YH (2009) J Controlled Release 133:2. doi: 10.1016/j.jconrel.2008.09.07410.1016/j.jconrel.2008.09.074 ↗
27. Tanaka T, Shiramoto S, Miyashita M, Fujishima Y, Kaneo Y (2004) Int J Pharm 277:39. doi: 10.1016/j.ijpharm.2003.09.05010.1016/j.ijpharm.2003.09.050 ↗
28. Kovář M, Mrkvan T, Strohalm J et al (2003) J Controlled Release 92:315. doi: 10.1016/s0168-3659(03)00340-710.1016/S0168-3659(03)00340-7 ↗
29. Levy-Nissenbaum E, Radovic-Moreno AF, Wang AZ, Langer R, Farokhzad OC (2008) Trends Biotechnol 26:44210.1016/j.tibtech.2008.04.006 ↗
30. Li XB, Schluesener HJ, Xu SQ (2006) Arch Immunol Ther Exp 54:17710.1007/s00005-006-0026-y ↗
31. Ke C-Y, Mathias CJ, Green MA (2003) Nucl Med Biol 30:811. doi: 10.1016/s0969-8051(03)00117-310.1016/S0969-8051(03)00117-3 ↗
32. Fujisawa T, Miyai H, Hironaka K et al (2012) Int J Pharm 436:564. doi: 10.1016/j.ijpharm.2012.07.02410.1016/j.ijpharm.2012.07.024 ↗
33. Hilgenbrink AR, Low PS (2005) J Pharm Sci 94:2135. doi: 10.1002/jps.2045710.1002/jps.20457 ↗
34. Liu S-Q, Wiradharma N, Gao S-J, Tong YW, Yang Y-Y (2007) Biomaterials 28:1423. doi: 10.1016/j.biomaterials.2006.11.01310.1016/j.biomaterials.2006.11.013 ↗
35. Lu Y, Low PS (2003) J Controlled Release 91:1710.1016/S0168-3659(03)00215-3 ↗
36. Leamon CP, Low PS (2001) Drug Discov Today 6:44. doi: 10.1016/s1359-6446(00)01594-410.1016/S1359-6446(00)01594-4 ↗
37. Sabharanjak S, Mayor S (2004) Adv Drug Deliv Rev 56:1099. doi: 10.1016/j.addr.2004.01.01010.1016/j.addr.2004.01.010 ↗
38. Zhu H, Liu F, Guo J, Xue J, Qian Z, Gu Y (2011) Carbohydr Polym 86:1118. doi: 10.1016/j.carbpol.2011.05.06110.1016/j.carbpol.2011.05.061 ↗
39. Zhao P, Wang H, Yu M et al (2010) Pharm Res 27:1914. doi: 10.1007/s11095-010-0196-510.1007/s11095-010-0196-5 ↗
40. Chen J, Li S, Shen Q (2012) Eur J Pharm Sci 47:430. doi: 10.1016/j.ejps.2012.07.00210.1016/j.ejps.2012.07.002 ↗
41. Wang F, Zhang D, Duan C et al (2011) Carbohydr Polym 84:1192. doi: 10.1016/j.carbpol.2011.01.01710.1016/j.carbpol.2011.01.017 ↗
42. Yang S-J, Lin F-H, Tsai H-M et al (2011) Biomaterials 32:2174. doi: 10.1016/j.biomaterials.2010.11.03910.1016/j.biomaterials.2010.11.039 ↗
43. Wan A, Sun Y, Li H (2008) Int J Biol Macromol 43:415. doi: 10.1016/j.ijbiomac.2008.07.01610.1016/j.ijbiomac.2008.07.016 ↗
44. Voinova MV, Galkin VL, Kosevich AM (1990) Bioelectrochem Bioenerg 24:143. doi: 10.1016/0302-4598(90)85017-c10.1016/0302-4598(90)85017-C ↗
45. Sułkowski WW, Pentak D, Nowak K, Sułkowska A (2005) J Mol Struct 744–747:737. doi: 10.1016/j.molstruc.2004.11.07510.1016/j.molstruc.2004.11.075 ↗
46. Cercek L, Cercek B, Ockey CH (1973) Biophysik 10:19510.1007/BF01190578 ↗